Sentence examples for which presents that from inspiring English sources

Figure 2b is a cross-sectional transmission electron microscope (TEM) image of Al/Al2O3/SiC which presents that Al2O3 was uniformly deposited as a fully amorphous film.

The effects of ATSE pretreatment under different conditions on glucan, xylan and lignin content of the pretreated corn stover are shown in Figure  2, which presents that ATSE pretreatment can drastically change the composition of corn stover.

The MSEs corresponding to different SNRs are plotted in Figure 10 which presents that the joint correction provides very small MSE only when SNR is above −12 dB.

The maps T and S have a coincidence point z = 7 4 ∈ Y (i.e., T ( 7 4 ) = 5 = S ( 7 4 ) ), which presents that the assertion (i) holds, and B and A have a coincidence point w = 5 4 ∈ Y (i.e., A ( 5 4 ) = 5 = B ( 5 4 ) ), which gives that the assertion (ii) holds.

In this figure, the RMSD variation of the complexes are lower than of Apo form (unbound protein), which presents that the conformation of MX2 with compounds will be more stable than unbound one.

After casting the silica solution loaded with Lac onto the MWCNTs/SPE, silica spheres can be found embedding into the Lac and connecting with each other (Figure 2C), which presented that Lac has been immobilized onto silica spheres successfully.

Tumor growths were observed and the macroscopic images were shown as isolated tumors, which presented that increased exogenous CXCR7 expression in HepG2 cells generated larger tumors than control cells, whereas silencing CXCR7 expression in LM3 cells formed smaller tumors.

Even within the broad brush definition of carcinomas from a particular organ, there are a range of mutations which present that will profoundly or sometimes more subtly change the paradigm for therapeutic intervention using multiple kinase inhibitor combinations.

However, this observation was inconsistent with our results, which presented that mutation in either BRAF V600E or KRAS was not related to the adverse clinicopathological features accompanied by advanced lymph node metastasis and III-IV disease stages.

Figure 8c shows the %degradation of dye by recovered catalysts, which presented that recovered TiO2/Pd and recovered TiO2/Pt degraded methyl violet 85 and 74%, respectively, within 20 min.

This result was similar to a previous study [ 28], which presented that the mean CRP level (12.8 ± 9.7 mg/dL) was higher in CPD patients than that (8 ± 4.5 mg/dL) in MHD patients.